Universal tumor screening for lynch syndrome: perspectives of patients regarding willingness and informed consent

被引：5
|
作者：
Subramonian, Anusree [1 ]
Smith, Doug
Dicks, Elizabeth [1 ]
Dawson, Lesa [2 ,3 ]
Borgaonkar, Mark [4 ]
Etchegary, Holly [1 ]
机构：
[1] Mem Univ, Fac Med, Clin Epidemiol, St John, NF, Canada
[2] Mem Univ, Fac Med, Gynecol Oncol Womens Hlth & Genet, St John, NF, Canada
[3] Eastern Hlth, Womens Hlth & Genet, St John, NF, Canada
[4] Mem Univ, Fac Med, Gastroenterol, St John, NF, Canada
来源：
PERSONALIZED MEDICINE | 2020年 / 17卷 / 05期
关键词：
colorectal cancer; lynch syndrome; patient oriented research; reflex testing; universal tumor screening; REVISED BETHESDA GUIDELINES; GENETIC TESTING STRATEGIES; COLORECTAL-CANCER SYNDROME; MICROSATELLITE INSTABILITY; FAMILY COMMUNICATION; REDUCING MORBIDITY; COST-EFFECTIVENESS; CLINICAL-CRITERIA; RESPONSE RATES; PRIMARY-CARE;
D O I：
10.2217/pme-2020-0026
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
Aim:Lynch Syndrome is associated with a significant risk of colorectal carcinoma (CRC) and other cancers. Universal tumor screening is a strategy to identify high-risk individuals by testing all CRC tumors for molecular features suggestive of Lynch Syndrome. Patient interest in screening and preferences for consent have been underexplored.Methods:A postal survey was administered to CRC patients in a Canadian province.Results:Most patients (81.4%) were willing to have tumors tested if universal tumor screening were available and were willing to discuss test results with family members and healthcare professionals. The majority (62.6%) preferred informed consent be obtained prior to screening.Conclusion:Patients were supportive of universal screening. They expected consent to be obtained, contrary to current practice across Canada and elsewhere.
引用
收藏
页码：373 / 387
页数：15
相关论文
共 50 条
  • [1] Universal tumor screening for Lynch syndrome: Assessment of the perspectives of patients with colorectal cancer regarding benefits and barriers
    Hunter, Jessica Ezzell
    Zepp, Jamilyn M.
    Gilmore, Mari J.
    Davis, James V.
    Esterberg, Elizabeth J.
    Muessig, Kristin R.
    Peterson, Susan K.
    Syngal, Sapna
    Acheson, Louise S.
    Wiesner, Georgia L.
    Reiss, Jacob A.
    Goddard, Katrina A. B.
    CANCER, 2015, 121 (18) : 3281 - 3289
  • [2] Universal tumor screening for Lynch syndrome: health-care providers' perspectives
    Bombard, Yvonne
    Rozmovits, Linda
    Sorvari, Anne
    Daly, Corinne
    Carroll, June C.
    Kennedy, Erin
    Rabeneck, Linda
    Baxter, Nancy N.
    GENETICS IN MEDICINE, 2017, 19 (05) : 568 - 574
  • [3] Identifying patients with Lynch syndrome using a universal tumor screening program in an integrated healthcare system
    Crain, Philip R.
    Zepp, Jamilyn M.
    Gille, Sara
    Jenkins, Lindsay
    Kauffman, Tia L.
    Shuster, Elizabeth
    Goddard, Katrina A. B.
    Wilfond, Benjamin S.
    Hunter, Jessica Ezzell
    HEREDITARY CANCER IN CLINICAL PRACTICE, 2022, 20 (01)
  • [4] Universal tumor screening for Lynch syndrome: perspectives of Canadian pathologists and genetic counselors
    Dicks, Elizabeth
    Pullman, Daryl
    Kao, Ken
    MacMillan, Andree
    Simmonds, Charlene
    Etchegary, Holly
    JOURNAL OF COMMUNITY GENETICS, 2019, 10 (03) : 335 - 344
  • [5] Informed consent and immunohistochemistry screening for Lynch syndrome
    Williams, Janet L.
    Williams, Marc S.
    GENETICS IN MEDICINE, 2011, 13 (09) : 848 - 849
  • [6] Informed consent to microsatellite instability and immunohistochemistry screening for Lynch syndrome
    Chubak, Barbara
    Heald, Brandie
    Sharp, Richard R.
    GENETICS IN MEDICINE, 2011, 13 (04) : 356 - 360
  • [7] Universal tumor screening for Lynch syndrome: perspectives of Canadian pathologists and genetic counselors
    Elizabeth Dicks
    Daryl Pullman
    Ken Kao
    Andrée MacMillan
    Charlene Simmonds
    Holly Etchegary
    Journal of Community Genetics, 2019, 10 : 335 - 344
  • [8] Universal screening for Lynch syndrome among patients with colorectal cancer: patient perspectives on screening and sharing results with at-risk relatives
    Hunter, Jessica Ezzell
    Arnold, Kathleen A.
    Cook, Jennifer E.
    Zepp, Jamilyn
    Gilmore, Marian J.
    Rope, Alan F.
    Davis, James V.
    Bergen, Kellene M.
    Esterberg, Elizabeth
    Muessig, Kristin R.
    Peterson, Susan K.
    Syngal, Sapna
    Acheson, Louise
    Wiesner, Georgia
    Reiss, Jacob
    Goddard, Katrina A. B.
    FAMILIAL CANCER, 2017, 16 (03) : 377 - 387
  • [9] Identifying patients with Lynch syndrome using a universal tumor screening program in an integrated healthcare system
    Philip R. Crain
    Jamilyn M. Zepp
    Sara Gille
    Lindsay Jenkins
    Tia L. Kauffman
    Elizabeth Shuster
    Katrina A.B. Goddard
    Benjamin S. Wilfond
    Jessica Ezzell Hunter
    Hereditary Cancer in Clinical Practice, 20
  • [10] Universal tumor screening for Lynch syndrome: Perceptions of Canadian pathologists and genetic counselors of barriers and facilitators
    Dicks, Elizabeth
    Pullman, Daryl
    Kao, Ken
    MacMillan, Andree
    Logan, Gabrielle S.
    Simmonds, Charlene
    Etchegary, Holly
    CANCER MEDICINE, 2019, 8 (07): : 3614 - 3622
12345